KIORA PHARMACEUTICALS INC Quarterly Current Ratio in % from Q3 2015 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Kiora Pharmaceuticals Inc quarterly Current Ratio history and growth rate from Q3 2015 to Q2 2024.
  • Kiora Pharmaceuticals Inc Current Ratio for the quarter ending June 30, 2024 was 1.1K %, a 293% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 1.1K +822 +293% Jun 30, 2024
Q1 2024 752 +537 +249% Mar 31, 2024
Q4 2023 339 +122 +56.5% Dec 31, 2023
Q3 2023 311 +45.4 +17.1% Sep 30, 2023
Q2 2023 281 -74.5 -21% Jun 30, 2023
Q1 2023 215 -207 -49% Mar 31, 2023
Q4 2022 217 -285 -56.8% Dec 31, 2022
Q3 2022 266 -101 -27.6% Sep 30, 2022
Q2 2022 355 +67.5 +23.4% Jun 30, 2022
Q1 2022 423 +85.2 +25.2% Mar 31, 2022
Q4 2021 502 +130 +35% Dec 31, 2021
Q3 2021 367 -124 -25.2% Sep 30, 2021
Q2 2021 288 -78 -21.3% Jun 30, 2021
Q1 2021 338 -18.1 -5.09% Mar 31, 2021
Q4 2020 372 +19.2 +5.45% Dec 31, 2020
Q3 2020 491 +195 +66% Sep 30, 2020
Q2 2020 366 +53.9 +17.3% Jun 30, 2020
Q1 2020 356 +57.6 +19.3% Mar 31, 2020
Q4 2019 352 +126 +55.8% Dec 31, 2019
Q3 2019 296 +160 +117% Sep 30, 2019
Q2 2019 312 +209 +202% Jun 30, 2019
Q1 2019 298 +213 +251% Mar 31, 2019
Q4 2018 226 +149 +194% Dec 31, 2018
Q3 2018 136 +55.8 +69.3% Sep 30, 2018
Q2 2018 103 +19.2 +22.9% Jun 30, 2018
Q1 2018 84.9 -3.56 -4.03% Mar 31, 2018
Q4 2017 76.9 -36.7 -32.3% Dec 31, 2017
Q3 2017 80.4 -80.9 -50.1% Sep 30, 2017
Q2 2017 84 -151 -64.2% Jun 30, 2017
Q1 2017 88.4 -174 -66.4% Mar 31, 2017
Q4 2016 114 -284 -71.4% Dec 31, 2016
Q3 2016 161 -27.8 -14.7% Sep 30, 2016
Q2 2016 235 Jun 30, 2016
Q1 2016 263 Mar 31, 2016
Q4 2015 398 Dec 31, 2015
Q3 2015 189 Sep 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.